Effects of herbalteas on CYP1A, CYP2C and CYP2D-mediated metabolic activities

被引:0
|
作者
Nishimura, Yuki [1 ]
Kurata, Norimitsu [1 ,2 ]
Iwase, Mariko [1 ]
Yasuhara, Hajime [1 ]
机构
[1] Showa Univ, Dept Pharmacol Sci, Sch Med, Shinagawa Ku, Tokyo 1428555, Japan
[2] Facult Arts Sci, Fujiyoshida, Yamanashi 4030005, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:209P / 209P
页数:1
相关论文
共 50 条
  • [31] Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy
    Dickmann, Leslie J.
    Tay, Suzanne
    Senn, Tauri D.
    Zhang, Huixia
    Visone, Anthony
    Unadkat, Jashuant D.
    Hebert, Mary F.
    Isoherranen, Nina
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (08) : 1677 - 1687
  • [32] Changes in CYP2C and CYP2D expression and activity during pregnancy in the rat: An opru study
    Dickmann, Leslie J.
    Senn, Tauri
    Tay, Suzanne
    Unadkat, Jashvant D.
    Isoherranen, Nina
    Hebert, Mary F.
    DRUG METABOLISM REVIEWS, 2006, 38 : 59 - 60
  • [33] Effects of H2S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
    Wang, Xianqin
    Han, Anyue
    Wen, Congcong
    Chen, Mengchun
    Chen, Xinxin
    Yang, Xuezhi
    Ma, Jianshe
    Lin, Guanyang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 24055 - 24063
  • [34] Expression and activities of hepatic cytochrome P450 (CYP1A, CYP2A and CYP2E1) in entire and castrated male pigs
    Brunius, C.
    Rasmussen, M. K.
    Lacoutiere, H.
    Andersson, K.
    Ekstrand, B.
    Zamaratskaia, G.
    ANIMAL, 2012, 6 (02) : 271 - 277
  • [35] Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
    Piver, B
    Berthou, F
    Dreano, Y
    Lucas, D
    TOXICOLOGY LETTERS, 2001, 125 (1-3) : 83 - 91
  • [36] INDUCTION OF VARIOUS CYTOCHROMES CYP2B, CYP2C AND CYP3A BY PHENOBARBITONE IN NONHUMAN-PRIMATES
    JONES, CR
    GUENGERICH, FP
    RICE, JM
    LUBET, RA
    PHARMACOGENETICS, 1992, 2 (04): : 160 - 172
  • [37] Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A.
    Kashuba, ADM
    Nafziger, AN
    Kearns, GL
    Leeder, JS
    Gotschall, R
    Rocci, ML
    Kulawy, RW
    Beck, DJ
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 153 - 153
  • [38] Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population
    Fernando de Andrés
    Catalina Altamirano-Tinoco
    Ronald Ramírez-Roa
    Carlos F Montes-Mondragón
    Pedro Dorado
    Eva M. Peñas-Lledó
    Adrián LLerena
    The Pharmacogenomics Journal, 2021, 21 : 140 - 151
  • [39] TRANSCRIPTIONAL REGULATION OF HUMAN CYP2C GENES - FUNCTIONAL COMPARISON OF CYP2C9 AND CYP2C18 PROMOTER REGIONS
    IBEANU, GC
    GOLDSTEIN, JA
    BIOCHEMISTRY, 1995, 34 (25) : 8028 - 8036
  • [40] Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes:: CYP1A1 or CYP1A2?
    Liu, N
    Zhang, QY
    Vakharia, D
    Dunbar, D
    Kaminsky, LS
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 389 (01) : 130 - 134